Blood Clot Retrieval Devices Market Size (By Stroke Type - Ischemic Stroke, Hemorrhagic Stroke (Rupturing Of Arteries), Transient Ischemic Attack; By Device Type - Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Ultrasound Assisted Devices; By End Users - Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers) - Global Industry Size, Share, Trends, And Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

Blood clot retrieval is a surgical technique that involves mechanical removal of blood clot from the patient’s brain. This technique is mainly used for the treatment of ischemic strokes caused due to the blood clots, which reduces the risk of paralysis, speech difficulties, and other stroke disabilities. A stroke is an unexpected loss of blood circulation in an area of the brain resulting into the loss of neurological functioning.

Market Dynamics

The improvement in technology and rising the prevalence of stroke will drive the growth of the global blood clot retrieval devices market. Growing demand for the blood clot retrieval devices in elderly patients, advanced patient selection using imaging and clinical results, use of an innovative instrument for guiding catheter placement are some of the major factors propelling the growth of the market. Moreover, rising demand of minimally invasive surgery and favorable reimbursement policies may fuel the growth of the market.

However, there are some restraining factors which may hamper the growth of the market such as lack of trained professionals, futile recanalization procedures which occur due to negative result and device malfunctioning during blood clot retrieval.

Market Classification and Overview

The global blood clot retrieval devices market is segment into stroke type, device type, end-user, and region.

On the basis of stroke type, the market is segmented into ischemic stroke, hemorrhagic stroke (rupturing of arteries), and transient ischemic attack.

Based on the device type, the market is segmented into mechanical embolus removal devices, penumbra blood clot retrieval devices, stent retrievers, and ultrasound assisted devices.

On the basis of end-user, the market is segmented into hospitals, diagnostic centers, clinics, ambulatory surgical centers, and others.

Regional Overview

Geographically, the global blood clot retrieval devices market is bifurcated into 4 major regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to dominate the global blood clot retrieval devices market during the forecast period 2018-2026, owing to the good reimbursement policies for diagnostic procedures.

Asia Pacific is expected to witness a strong growth during the forecasted period owing to the rising number of local players providing blood clot retrieval devices at lower cost, especially in countries such as China. Increasing number of patient population is also estimated to drive the market in this region.

Europe is expected to hold the major share during the forecasted period owing to the rise in demand for the blood clot retrieval devices, improved technological development, and better government policies. Additionally, LAMEA is expected to witness a moderate growth due to poor reimbursement policies and lack of knowledge regarding the devices.

Report Coverage

Market

Blood Clot Retrieval Devices Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Stroke Type, Device Type, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, 

Player Profiling, Value Chain Analysis

Market Participants

The global blood clot retrieval devices market comprises of some of the major players such as 

  • Boston Scientific Corp.
  • Bayer HealthCare LLC
  • Medtronic plc. 
  • Argon Medical Devices Inc.
  • Teleflex Incorporated
  • Penumbra Inc.
  • AngioDynamics, Inc.
  • Johnson and Johnson, Inc.
  • Terumo Corporation
  • ECKOS Corporation

Market Segmentation

By Stroke Type

  • Ischemic Stroke (blood clot)
  • Hemorrhagic Stroke (rupturing of arteries)
  • Transient Ischemic Attack

By Device Type

  • Mechanical Embolus Removal Devices
  • Penumbra Blood Clot Retrieval Devices
  • Stent Retrievers
  • Ultrasound Assisted Devices

By End-User

  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary